Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
A staggering 22% of Nigerians living with HIV have faced discrimination in various aspects of their lives, according to the ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
Juniper House, the first end-of-life care facility for people dying of AIDS and AIDS-related complexes in Oregon, was ...
“In the design and implementation of our interventions, we should ensure that we fully involve people living with HIV/AIDS and patients with syphilis and hepatitis. We should also engage ...
8don MSN
The monologue-style drama is about a mother torn between love for her gay son and her conservative husband and faith ...
Elon Musk claims he mistakenly fired Ebola prevention workers, then quickly fixed the error. But Ebola programs are still in ...
Phase 1 Data Indicate Potential for Use of Once-Yearly Lenacapavir for HIV Prevention, with Plans to Launch a Phase 3 Trial in 2H 2025 – ...
The year 2024 was a mixed bag in the fight against AIDS. Modern antiviral therapies have turned HIV into a chronic ... For comparison, a high-end graphic design laptop typically has two GPUs.
USAID was the pace-setter on locally led development," says Moses Isooba of the Uganda National NGO Forum. But now that it ...
In HIV-positive MSM, pain severity was significantly associated with pain management experiences and unhealthy alcohol use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback